Reassess for MRSA Risk Factors and Consider Switching to MRSA-Active Antibiotics
If your patient with cellulitis is failing cephalexin after 5 days, you should immediately reassess for MRSA risk factors and switch to an antibiotic with MRSA coverage such as trimethoprim-sulfamethoxazole, doxycycline, or clindamycin for outpatient management, or consider hospitalization with IV vancomycin if systemic signs are present. 1
Critical Decision Points
The IDSA guidelines explicitly state that treatment should be extended if infection has not improved within 5 days 1. However, simple extension of cephalexin is inappropriate when treatment is clearly failing—you need to reassess and escalate.
Immediate Assessment Required
Look specifically for these MRSA risk factors that should trigger coverage:
- Purulent drainage (even if initially appeared non-purulent)
- Penetrating trauma at the site
- Injection drug use
- Known MRSA colonization or previous MRSA infection
- Systemic signs (fever, tachycardia, hypotension—SIRS criteria)
- Severe immunocompromise
Outpatient Management Algorithm
If patient is stable without systemic signs:
- Switch to oral MRSA-active antibiotic:
The evidence strongly favors TMP-SMX in MRSA-prevalent areas, with significantly lower failure rates compared to cephalexin (adjusted OR 4.22 for failure with non-MRSA-active antibiotics) 2.
Hospitalization Criteria
Admit for IV vancomycin if:
- SIRS present (fever, tachycardia, tachypnea, abnormal WBC)
- Altered mental status
- Hemodynamic instability
- Concern for deeper/necrotizing infection
- Severe immunocompromise
- Poor adherence anticipated
For hospitalized patients requiring broad coverage, vancomycin plus piperacillin-tazobactam or a carbapenem is recommended 1.
Important Caveats
Cephalexin has documented higher failure rates: A retrospective study showed 40% failure with cephalexin versus 20% with comparator antibiotics (OR 2.62) 4. In MRSA-prevalent regions, 62% of cultured cellulitis isolates were MRSA 2, making empiric streptococcal-only coverage inadequate for treatment failures.
Consider obtaining cultures at this point—while not routinely recommended initially, blood cultures and wound cultures/aspirates should be obtained in treatment failures to guide further therapy 1.
Address predisposing factors:
- Elevate the affected extremity
- For lower extremity cellulitis, examine interdigital toe spaces for tinea pedis and treat if present
- Address underlying edema or skin breakdown
Duration After Switch
Continue the new antibiotic for a total treatment course (including the initial 5 days) that extends until clinical improvement is clearly established, typically 7-14 days total depending on response 1.